Approval · Notice of Compliance 7916 · 2006
COVERA-HS: Notice of Compliance 7916
Issued May 2, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7916
- Date
- May 2, 2006
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the product monograph
- Therapeutic class
- Antihypertensive and anti-anginal agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COVERA-HS | Not yet assigned | — |
Medicinal ingredients
- VERAPAMIL HCL 180 MG per TAB
- VERAPAMIL HCL 240 MG per TAB